Using 22C3 Anti-Pd-L1 Antibody Concentrate on Biopsy and Cytology Samples From Non-Small Cell Lung Cancer Patients

Journal of Visualized Experiments - United States
doi 10.3791/58082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MyJove Corporation

Related search

P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Prospective Observational Study to Assess PD-L1 Expression in Small Biopsy Samples for Non-Small-Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

Interchangeability of PD-L1 Laboratory-Developed Test by 22C3 Antibody Concentrate Among Ihc Platforms in Gastric Cancer

Pathology
Forensic MedicinePathology
2020English

P2.09-02 Comprehensive Assessment of PD-L1 Immunohistochemistry on Paired Tissue and Cytology Specimens in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.09-03 Challenges in PD-L1 Immunoexpression in Liquid Based Cytology Samples of Advanced Stage Non-Small Cell Lung Carcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion

2018English

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

Anti-Pd-1/Pd-L1 Antibody Versus Conventional Chemotherapy for Previously-Treated, Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy